CERE1EUR

Cerevel Therapeutics Holding

-$6.5B

Net Activity

Institutions Holding

2

Popularity Rank

#16957

Avg Weight

0.00%

Total Value

$20.7K

Ownership Trend

2 institutions currently hold CERE1EUR, with 0 net buyers and 55 net sellers this quarter.

Institutional Moves

Institutional Moves (Q3 2024)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

55

Net Buying Institutions

0

Key Holders

View all 2 holding institutions

Quarterly Activity

Recent Activity

+$0.0

Total Buy Value

$816.9M

Total Sell Value

New buy0
Trim0
Add0
Sold out55

0

Net Buyers

55

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CEREVEL THERAPEUTICS HOLDING (CERE1EUR)?
Major stakeholders currently include IFP Advisors, Inc ($15.5K), Blue Trust, Inc. ($5.2K). Based on the latest 13F filings, there are a total of 2 tracked investment funds and institutions maintaining positions in CERE1EUR.
What is the overall institutional sentiment toward CERE1EUR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $6.5B, driven by 0 managers accumulating shares while 55 reduced their exposure.
Which institutions have been selling or reducing their CERE1EUR positions?
In the latest period, 0 funds trimmed their holdings, and 55 managers completely exited their positions. The aggregate reported sell value was $816.9M.
Are there any notable investors adding CERE1EUR to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in CERE1EUR during the last reporting period.

Related Stocks